Three-dimensional Digital Breast Tomosynthesis Versus Digital Mammography
NCT ID: NCT07145892
Last Updated: 2025-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
255 participants
OBSERVATIONAL
2024-06-01
2025-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
NCT00722059
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887
New Mammographic Techniques Versus MRI in Assessment of Breast Lesions
NCT06089148
Value of Digital Breast Tomosynthesis in Breast Lesions
NCT06687902
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
NCT00208871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mammography is the only study for screening in asymptomatic patients, and it is the initial imaging study in the diagnosis of symptomatic patients, with a sensitivity for suspicious lesions of 86% and a specificity of 57%.
In recent years, a significant effort has been expended to develop new approaches to breast imaging, one of which is the use of digital breast tomosynthesis (DBT), which is a pseudo three-dimensional digital mammography system that produces a series of thin-section reconstructed images from low-dose X-ray projections at multiple angles.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
Categorized 130 women aged from 30 to 40 years.
Three-dimensional Digital Breast Tomosynthesis
Patients underwent three-dimensional digital breast tomosynthesis.
Two-dimensional Digital Mammography
Patients underwent two-dimensional digital mammography
Group II
Categorized 115 women aged from 40 to 50 years.
Three-dimensional Digital Breast Tomosynthesis
Patients underwent three-dimensional digital breast tomosynthesis.
Two-dimensional Digital Mammography
Patients underwent two-dimensional digital mammography
Group III
Categorized 10 females aged above 50 years.
Three-dimensional Digital Breast Tomosynthesis
Patients underwent three-dimensional digital breast tomosynthesis.
Two-dimensional Digital Mammography
Patients underwent two-dimensional digital mammography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three-dimensional Digital Breast Tomosynthesis
Patients underwent three-dimensional digital breast tomosynthesis.
Two-dimensional Digital Mammography
Patients underwent two-dimensional digital mammography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who refuse to fill the consent form.
30 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The General Authority for Teaching Hospitals and Institutes
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hekmat Samir Baumey
Lecturer of Diagnostic Radiology, Damnhour National Medical Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Authority for Teaching Hospitals and Institutes
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HD000217
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.